This week: tirzepatide vs semaglutide results from 20,000+ patients, new data on the start-and-stop journey, groundbreaking research on GLP-1s rewiring impulsive behaviour, and why your step count matters more than you think.Plus Father's Day waffle, World Cup chat, and the first ever fully integrated sponsor on the channel.This week's stories: Tirzepatide vs Semaglutide: Real-world data from 20,000+ patients The Start & Stop trend 58% restart within 2 years GLP-1s and impulsive behaviour: the brain rewiring study Physical activity drop & the muscle loss warning Check out all the update videos on YouTube: YouTube Weekly Videos *The episodes in this series are recorded as YouTube videos
Advantage: Sermorelin, based on stronger mechanistic and clinical evidence for sleep architecture improvement
CJC-1295 mimics the activity of growth hormone-releasing hormone (GHRH) and signals your pituitary gland to release more growth hormone (GH) over a sustained period, and increases its levels in the body
10.1186/1471-2407-12-546 BMC Cancer 19 DeAngelisT.ChenJ.WuA.PriscoM.BasergaR
They are usually safe but can cause problems for some people
Shame can inhibit individuals from seeking help and sharing their experiences, potentially exacerbating feelings of isolation and distress (20)